This document discusses nephrolithiasis and urolithiasis, which refer to kidney stones and urinary tract stones respectively. Stones form when substances in urine crystallize. Risk factors include hypercalcemia, dehydration, diet, genetics, and certain medical conditions. Stones are diagnosed using imaging tests and urine/blood tests. Treatment depends on stone size and location, and may include increased fluid intake, shockwave lithotripsy, ureteroscopy, or surgery to remove stones. Nursing care focuses on pain management, preventing infection and obstruction, and educating patients on prevention of recurrent stones.
Urolithiasis is a common disease that is estimated to
produce medical costs of $2.1 billion per year in the United States alone.
Renal colic affects approximately 1.2 million people
each year in USA and accounts for approximately 1% of
all hospital admissions.
Most active emergency departments (EDs) manage
patients with acute renal colic every day.
Urolithiasis is a common disease that is estimated to
produce medical costs of $2.1 billion per year in the United States alone.
Renal colic affects approximately 1.2 million people
each year in USA and accounts for approximately 1% of
all hospital admissions.
Most active emergency departments (EDs) manage
patients with acute renal colic every day.
Pyelonephritis
It is the inflammation of the kidney & upper urinary tract that usually results from the bacterial infection of the bladder.
Pyelonephritis can be classified in several different catagories:
-acute pyelonephritis
-chronic pyelonephritis
-xanthogranulomatous pyelonephritis
Pyelonephritis
It is the inflammation of the kidney & upper urinary tract that usually results from the bacterial infection of the bladder.
Pyelonephritis can be classified in several different catagories:
-acute pyelonephritis
-chronic pyelonephritis
-xanthogranulomatous pyelonephritis
Kidney stones (also called renal calculi, nephrolithiasis or urolithiasis) are hard deposits made of minerals and salts that form inside your kidneys. Diet, excess body weight, some medical conditions, and certain supplements and medications are among the many causes of kidney stones.
CHOLELITHIASIS, NEPHROLITHIASIS SECONDARY HYPERTENSION, DM TYPE 2, HYDRONEPH...Jack Frost
CHOLELITHIASIS, NEPHROLITHIASIS
SECONDARY HYPERTENSION, DM TYPE 2, HYDRONEPHROSIS
This presentation contains real names of persons involve of this particular study. This names should not be copied or rewritten. Used the data of this study as basis only. All rights reserved 2009.
Urolithiasis Is the process of forming stones in the kidney, bladder or urethra
Kidney stones(calculi) are formed of minerals deposits commonly calcium oxalate and calcium phosphate; however uric acid, struvite and cystine are also calculus formers.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
2. NEPHROLITHIASIS AND UROLITHIASIS
Nephrolithiasis refers to renal stone .
Urolithiasis refers to the presence of stones in the
urinary system.
Stones, or calculi, are formed in the urinary tract
from the kidney to bladder by the crystallization of
substances excreted in the urine.
2
3. Causes and predisposing factors of
kidney stones
Hypercalcemia and hypercalciuria
Excessive intake of vitamin D, milk, and alkali
Chronic dehydration
Fluid intake,
Immobility
Diet high in purines and abnormal purine
metabolism (hyperuricemia and gout)
3
4. Contd…
Genetic predisposition (cystinuria)
Chronic urinary tract infection (Struvite stone)
Chronic obstruction with stasis of urine, foreign
bodies within the urinary tract
Excessive oxalate absorption in inflammatory
bowel disease and bowel resection or ileostomy
Living in mountainous, desert, or tropical areas
4
5. Contd…
Some medications
some diuretics
calcium-containing antacids
Protease inhibitors: Indinavir sulfate
Steroids:
Dietary factors:
inadequate fluid intake predisposes to dehydration
high intake of animal protein,
a high-salt diet,
excessive vitamin D supplementation,
excessive intake of oxalate-containing foods such as
spinach
5
6. Medical conditions leading kidney
stone
Gout (uric acid stones)
Hyperparathyroidism
kidney diseases such as renal tubular acidosis
Chronic diseases such as diabetes and
hypertension.
Inflammatory bowel disease
Those who have undergone intestinal bypass or
ostomy surgery
6
7. Pathophysiology
Inhibitors of stone formation:
Stones can form when there is a deficiency of
substances that normally prevent crystallization
in the urine, such as Citrate,magnesium,
nephrocalcin, and uropontin.
(that inhibit the nucleation, growth, and
aggregation of calcium-containing crystals)
7
8. Supersaturation of urine:
When the urine becomes supersaturated with one
or more calculogenic (crystal-forming) substances,
a seed crystal may form through the process of
nucleation.
8
9. Different types of kidney stones
Calcium stones: Calcium stones are most common
substance and found in up to 90% of stone.
They are more common in men between age 20 - 30.
The peak onset is during a person’s 20.
They may range from very small particles, often called
SAND or GRAVEL to giant staghorn calculi.
Calcium can combine with other substances, such as
oxalate (the most common substance), phosphate, or
carbonate, to form the stone.
9
11. Causes of hypercalciuria
A high rate of bone reabsorption E.g Paget’s disease,
hyperparathyroidism, cushing’s syndrome, immobility etc
Increase calcium reabsorption in gut as in milk-alkali
syndrome,& excessive intake of vitamin D.
Impaired renal tubular absorption of filtered calcium as
in renal tubular acidosis.
11
12. Contd….
Oxalate: It is the second most common stone,
which is relatively insoluble in urine.
The mechanism of the oxalate availability is
unclear but may be closely related to diet.
Oxalate is present in certain foods such as spinach.
It's also found in vitamin C supplements.
Diseases of the small intestine increase risk of
these stones.
12
14. Cystine stones: Cystine stones can form in people
who have cystinuria. This disorder runs in families
and affects both men and women.
Uric acid stones: Uric acid stones are more common
in men than in women. They can occur with gout or
chemotherapy.
Struvite stones: Struvite stones are mostly found in
women who have a urinary tract infection.
These stones can grow very large and can block the
kidney, ureter, or bladder.
14
19. Signs and symptoms
While some kidney stones may not produce
symptoms (known as "silent" stones)
The main symptom is severe pain that starts
suddenly and may go away suddenly:
Pain may move to groin area (groin pain) or
testicles (testicle pain)
19
20. Pain pattern depends on site of
obstruction
Calyx: Flank or costovertebral angle
pain,hematuria, abdominal distention
Ureteropelvic junction: pain at flank or
costovertebral junction, migrating to groin and
testicle/libia minora
Ureterovesical junction: Urgency, frequency,
genital pain
20
21. Contd..
Renal colic pain
Pain relief is immediate after stone passage.
Large ureteral stones produce symptoms of
obstruction as they pass down the ureter (ureteral
colic).
Bladder stones produce symptoms similar to cystitis.
21
23. Diagnostic Evaluation
History taking:
Dietary and medication histories and family history of
renal stones
Ultrasonography
X-ray KUB (Kidney, Ureter & Bladder)
IVU ( Intra Venous Urography) to determine site
and evaluate degree of obstruction
Spiral CT scan
23
24. Contd…
Urinalysis :hematuria and pyuria; pH < 5.5
indicates uric acid stone; > 7.5 indicates struvite
stone; urine culture and drug sensitivity studies to
detect infection.
Serum kidney function tests, electrolytes,
calcium, phosphorus, uric acid, and magnesium
levels; serum parathyroid hormone may also be
evaluated
24
26. Management
Non - Operative
General Principles
If small stone (< 5 mm) and able to treat as outpatient,
80% will pass stone spontaneously with hydration,
pain control, and reassurance.
Intravenous hydrations followed by intravenous
frusemide
Hospitalized for intractable pain, persistent vomiting,
high-grade fever, obstruction with infection, and
solitary kidney with obstruction.
26
28. ESWL contd..
Noninvasive technique and treatment of choice for
stones less than 2 cm in diameter (80% of stones
fall into this category) and located in the ureter
above the iliac crest.
28
29. ESWL contd…
High-energy shock waves are
directed at the kidney stone (
500-1500 shock wave)
Position of the kidney stone
is located by fluoroscopy, and
the shock waves are targeted
directly at the stone.
The shock waves do not
affect soft tissue.
29
30. ESWL contd…
ESWL eliminates need for
surgery in majority of patients
and can be repeated for
recurrent stones with no
apparent risk to kidney
structure or function.
Complications include pain,
urinary infection, and
temporary bleeding around
kidney.
30
32. Percutaneous Nephrostolithotomy
Percutaneous
nephrolithotomy (PCNL) is a
surgical procedure to remove
stones from the kidney by a small
puncture wound (up to about 1
cm) through the skin.
It is most suitable to remove
stones of more than 2 cm in size
and which are present near the
Pelvic region.
It is usually done under general
anesthesia or spinal anesthesia.
32
33. Contd….
For stones in renal collecting
system or upper portion of ureter
and larger than 2.5 cm in diameter.
Under ultrasound guidance, a
needle is advanced into collecting
system; guide wire is advanced
into renal pelvis or ureter.
33
34. Contd…
Tract is dilated with mechanical dilators or
high-pressure balloon dilator until
nephroscope can be inserted up against
stone.
Stones can be broken apart with hydraulic
shock waves or a laser beam administered
by way of nephroscope fragments are
removed using forceps, graspers, or basket
34
35. Complications of PCNL
Injury to the colon sepsis
Injury to the blood vessels
Urinary leak may persist for a few days.
35
36. Uretero-renoscopic Lithotripsy (URSL)
Ureterorenoscopy is a procedure ,where the kidney
stones are removed mechanically using a thin
telescope called ureteroscope is passed through the
urethra into the bladder, through to the ureter or to
the kidneys where the stone I s stuck .
The stones are broken down into smaller pieces using
lithotripsy.
36
37. Contd….
This is performed under general anesthetic and
sometimes a plastic tube called a stent is inserted
temporarily to facilitate the movement of the stone
particles into the bladder.
This is most effective for stones having size of 15 mm
or more.
37
38. Open Surgical Procedures
Indicated for only 1% to 2% of all stones.
Pyelolithotomy removal of stones from kidney
pelvis
Nephrolithotomy a incision into kidney for
removal of stone
38
39. Contd…
Nephrectomy a removal of kidney; indicated
when kidney is extensively and irreparably
damaged and is no longer a functioning organ;
partial nephrectomy sometimes done.
Ureterolithotomy a removal of stone in ureter
Cystolithotomy a removal of stone from bladder
39
40. Complications of renal stone
Calculous hydronephrosis
Calculous pyonephrosis
Renal failure
Squamous cell carcinoma
40
41. Nursing Assessment
Obtain history focusing on family history of
calculi, episodes of dehydration, prolonged
immobility, UTI, dietary and medication history.
Assess pain location and radiation; assess level of
pain using a scale of 1 to 10.
Observe for presence of associated symptoms:
nausea, vomiting, diarrhea, abdominal distention.
41
42. Contd…
Monitor for signs and symptoms of UTI, such as
chills, fever, dysuria, frequency. Examine urine for
hematuria.
Observe for signs and symptoms of obstruction,
such as frequent urination of small amounts,
oliguria, anuria.
42
43. Nursing Diagnoses
Acute Pain related to inflammation, obstruction, and
abrasion of urinary tract by migration of stones
Impaired Urinary Elimination related to blockage of
urine flow by stones
Risk for Infection related to obstruction of urine flow
and instrumentation during treatment
Deficient knowledge regarding prevention of
recurrence of renal stones
43
44. Nursing Interventions
Controlling Pain
Give prescribed opioid analgesic (usually I.V. or
I.M.) until cause of pain can be removed.
Monitor patient closely for increasing pain; may
indicate inadequate analgesia.
Very large doses of opioids are typically required to
relieve pain, so monitor for respiratory depression
and drop in blood pressure
44
45. Controlling pain contd…
Encourage patient to assume position that brings
some relief.
Reassess pain frequently using pain scale.
Administer antiemetic if needed.
45
46. Maintaining Urine Flow
Administer fluids orally or I.V. (if vomiting) to
reduce concentration of urinary crystalloids and
ensure adequate urine output.
Monitor total urine output and patterns of voiding.
report oliguria or anuria.
Strain all urine through strainer or gauze to
harvest the stone; uric acid stones may crumble.
Crush clots, and inspect sides of urinal/bedpan for
clinging stones or fragments 46
47. Contd..
For outpatient treatment, the patient may use a
coffee filter to strain urine.
Help patient to walk, if possible, because
ambulation may help move the stone through the
urinary tract.
47
48. Controlling Infection
Administer parenteral or oral antibiotics as
prescribed during treatment, and monitor for
adverse effects.
Assess urine for color, cloudiness, and odor.
Obtain vital signs, and monitor for fever and
symptoms of impending sepsis (tachycardia,
hypotension).
48
49. Prevention of Recurrent Stone
Formation
For patients with calcium oxalate stones
Instruct on diet avoid excesses of calcium and
phosphorus; maintain a low-sodium diet
Teach purpose of drug therapy allopurinol
therapy to reduce uric acid concentration.
49
50. Contd…
For patients with uric acid stones
Teach methods to alkalinize urine to enhance
urate solubility.
Instruct on testing urine pH.
Teach purpose of taking allopurinol to lower
uric acid concentration.
Provide information about reduction of dietary
purine intake (low protein red meat, fish, fowl).
50
51. For patients with infection (struvite) stone
Teach signs and symptoms of urinary infection
(in patients with neurologic or spinal cord
disease, teach use of dipsticks to evaluate urine
for nitrites and leukocytes); encourage him to
report infection immediately; must be treated
vigorously.
Try to avoid prolonged periods of recumbency
slows renal drainage and alters calcium
metabolism.
51
52. For patients with cystine stones(occur in
cystinuria, a hereditary disorder of amino acid
transport).
Teach patient to alkalinize urine by taking
sodium bicarbonate tablets (Soda Mint) to
increase cystine solubility; instruct patient how
to test urine pH with a pH indicator.
Teach patient about drug therapy with D-
penicillamine (Depen) to lower cystine
concentration
Explain importance of maintaining drug therapy
consistently.
52
53. For all patients with stone disease
Explain need for consistently increased fluid
intake (24-hour urinary output greater than 2 L)
lowers the concentration of substances involved
in stone formation.
Drink enough fluids to achieve a urinary
volume of 2,000 to 3,000 mL or more every 24
hours.
Drink larger amounts of fluid during periods
of strenuous exercise, if patient perspires
freely.
Take fluids in evening to guarantee a high
urine flow during the night.
53
54. Encourage a diet low in sugar and animal
proteins refined carbohydrates appear to lead to
hypercalciuria and urolithiasis; animal proteins
increase urine excretion of calcium, uric acid,
and oxalate.
Increase consumption of fiber inhibits calcium
and oxalate absorption.
Save any stone passed for analysis. (Only
patients with more than one episode of
urolithiasis are advised to have a metabolic
evaluation.)
54
55. References
http://en.wikipedia.org/wiki/Kidney_stone retrieved
on 2012/08/08
http://www.medicinenet.com/kidney_stone/article.ht
m retrieved on 2012/08/08
Nettina, Sandra , M., & Elizabeth ,J. (2006).
Lippincott Manual of Nursing Practice. (8th
ed.).published by Lippincott Williams & Wilkins.
Black, J.M., & Hawks, J.H.(2009).Medical Surgical
Nursing.(8th ed.). Published by Elsevier India.
56